Standout Papers

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer 2006 2026 2012 2019 2.4k
  1. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer (2006)
    Charles E. Geyer, Deborah Lindquist et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 18 from Science/Nature 105 standout
Sub-graph 1 of 19

Citing Papers

CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Targeting HER2-positive breast cancer: advances and future directions
2022 Standout
50 intermediate papers

Works of Deborah Lindquist being referenced

Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial
2012
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Deborah Lindquist 2460 915 630 792 22 2.9k
Steven Stein 2973 1184 743 978 20 3.6k
Steven R. Olsen 3008 849 701 1372 23 3.9k
Michael W. Lu 2763 981 514 1541 18 3.5k
Neville Davidson 3634 1151 779 864 25 4.9k
Stephen D. Rubin 2583 1312 658 791 17 3.9k
Ellie Guardino 3842 1234 604 2157 30 4.6k
R. Mass 2431 1177 496 585 43 3.4k
Jacques Gaudreault 1336 1173 462 678 36 3.2k
Scott N. Holden 2208 849 423 810 42 3.6k
Cammie Rinehart 1654 565 327 715 19 2.8k

All Works

Loading papers...

Rankless by CCL
2026